Enhancing Aromatic L‐amino Acid Decarboxylase Activity: Implications for L‐DOPA Treatment in Parkinson's Disease
- 11 November 2008
- journal article
- review article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 14 (4) , 340-351
Abstract
Aromatic L‐amino acid decarboxylase (AAAD) is an essential enzyme for the formation of catecholamines, indolamines, and trace amines. Moreover, it is a required enzyme for converting L‐DOPA to dopamine when treating patients with Parkinson's disease (PD). There is now substantial evidence that the activity of AAAD in striatum is regulated by activation and induction, and second messengers play a role. Enzyme activity can be modulated by drugs acting on a number of neurotransmitter receptors including dopamine (D1–4), glutamate (NMDA), serotonin (5‐HT1A, 5‐HT2A) and nicotinic acetylcholine receptors. Generally, antagonists enhance AAAD activity; while, agonists may diminish it. Enhancement of AAAD activity is functional, as the formation of dopamine from exogenous L‐DOPA mirrors activity. Following a lesion of nigrostriatal dopaminergic neurons, AAAD in striatum responds more robustly to pharmacological manipulations, and this is true for the decarboxylation of exogenous L‐DOPA as well. We review the evidence for parallel modulation of AAAD activity and L‐DOPA decarboxylation and propose that this knowledge can be exploited to optimize the formation of dopamine from exogenous L‐DOPA. This information can be used as a blue print for the design of novel L‐DOPA treatment adjuvants to benefit patients with PD.Keywords
This publication has 115 references indexed in Scilit:
- Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmissionPharmacology & Therapeutics, 2007
- A comparison of the progression of early Parkinson's disease in patients started on ropinirole or L-dopa: an 18 F-dopa PET studyJournal of Neural Transmission, 2002
- Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's diseaseNeurological Sciences, 2002
- Effects of glutamate antagonists on the activity of aromatic L-amino acid decarboxylaseAmino Acids, 1998
- Phorbol Ester Administration Transiently Increases Aromatic l‐Amino Acid Decarboxylase Activity of the Mouse Striatum and MidbrainJournal of Neurochemistry, 1994
- NSD-1015 alters the gene expression of aromaticl-amino acid decarboxylase in rat PC12 pheochromocytoma cellsNeurochemical Research, 1993
- Evidence for Cyclic AMP‐Mediated Increase of Aromatic L‐Amino Acid Decarboxylase Activity in the Striatum and MidbrainJournal of Neurochemistry, 1993
- Modulation of Retinal Aromatic l‐Amino Acid Decarboxylase via α2 AdrenoceptorsJournal of Neurochemistry, 1989
- Aromatic l‐Amino Acid Decarboxylase Activity of the Rat Retina Is Modulated In Vivo by Environmental Light Maria HadjiconstantinouJournal of Neurochemistry, 1988
- Exposure to Light Accelerates the Formation of Dopamine from Exogenous L-DOPA in the Rat RetinaJournal of Ocular Pharmacology and Therapeutics, 1985